The analysis by Ontada tracked testing rates withing the US Oncology Network for PD-L1, FGFR2/3, and HER2 biomarkers over 10 years.

The firms launched the global Phase II bladder cancer trial for autogene cevumeran after seeing early success in pancreatic cancer.

In a Phase Ia trial in ovarian cancer, a strong neutralizing antibody response correlated with better disease control and ...

The European Commission approval was based on results showing the immunotherapy regimen improved event-free survival in a Phase III trial.

The firm announced deals with UMass Chan Medical School and Quiver to further its ambitions to develop transformative treatments for the condition.

The treatment has been used in a trial to treat children with GM1 gangliosidosis, but if the FDA allows, this would be the ...

The baby boy with a rare urea cycle disorder received the bespoke therapy within a few months of birth and is doing well, ...

The baby boy received the bespoke therapy within a few months of birth and is doing well, according to a presentation at ASGCT.